Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Delays 2009 Earnings Report, Citing Potential Asset Impairment, Doubt Over Ability to Continue


This article was originally published April 1.

Helicos BioSciences said this week that it will file its 2009 annual earnings report late, citing that it has not yet determined potential asset impairment charges that could be material to its results, and whether substantial doubt exists over its ability to continue its business.

The company now plans to file its 2009 earnings report on or before April 15.

In a document filed with the US Securities and Exchange Commission yesterday, Helicos said it was unable to file its report for the year ended Dec. 31, 2009, by the March 31 deadline "without unreasonable effort or expense" because it is still reviewing "the application of accounting principles relating to the potential impairment of certain long lived assets and the recoverability of certain current assets, primarily inventory."

The company also said it was "unable to finish developing other narrative information" in order to complete the filing on time. The potential asset impairment charges, it said, could be material to its operations and financial position.

In addition, Helicos said it is currently evaluating whether "substantial doubt exists over the company's ability to continue as a going concern."

As of early November 2009, Helicos had $8.4 million in cash and cash equivalents and expected approximately $5 million in receipts from instrument and reagent sales during the fourth quarter of 2009 and the first quarter of 2010. These funds would have allowed it to operate through the first quarter of this year, the company estimated at the time (see In Sequence 11/9/2009).

Since then, Helicos has announced the sale of sequencing instruments to the Leiden University Medical Center in the Netherlands, the Turku Centre for Biotechnology in Finland, and the St. Laurent Institute, and has signed an agreement with Stanford University to install a second Helicos Genetic Analysis System there.

Last fall, the company said in an SEC filing that it had extended the lease for its facilities until the end of March 2010 (see In Sequence 10/20/2009).

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.